Test of a New Gel-based Colon Cleansing Agent Compared to Moviprep

Zealand University Hospital

Status and phase: Unknown; Phase 1

Conditions: Pharmacological Action

Treatments: Drug: A 06 ad

Study type: Interventional

Funder types: Other

Identifiers

NCT03904303

REG-014-2018

Details and patient eligibility

About

Crossover study comparing Moviprep (for bowel cleansing) with a new gel-based colon cleansing agent before colonoscopy

Full description

Crossover study comparing Moviprep (for bowel cleansing) with a new gel-based colon cleansing agent before colonoscopy.

Study performed in health subjects.

Enrollment: 16 estimated patients

Sex: All

Ages: 18 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy

Exclusion criteria

• Allergy to content of products

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Double Blind

---

16 participants in 2 patient groups

Geloprep

Experimental group

Description:

Novel and patented Polyethylene glycol 3350 mixture

Treatment:

Drug: A 06 ad

Moviprep

Active Comparator group

Description:

Standard of care Polyethylene glycol 3350 mixture

Treatment:

Drug: A 06 ad